Researchers have begun recruiting volunteers for the phase 1B clinical trial of the new Alzheimer’s vaccine, ALZ-101. The Swedish biopharma company, Alzinova AB has developed an Alzheimer’s vaccine that directly targets amyloid-beta oligomers within patients.
New Alzheimer's Vaccine Begins Clinical Trial - MEDizzy Journal
New Alzheimer's Vaccine Begins Clinical Trial - MEDizzy Journal
Comments
Post a Comment